Inventor · disambiguated record
Samuel D. Waksal
Also filed as: WAKSAL SAMUEL · WAKSAL SAMUEL D
4 granted patents·16 pending applications·7 citations·filing 2004–2023
62Inventor score
Files withKADMON CORP LLC5L4 BIO LLC5WAKSAL SAMUEL3GRAVITON BIOSCIENCE BV2KADMON PHARMACEUTICALS LLC2
Top patents by PatentIndex Score
20 records- 0184US10407502B2Immunomodulatory agentsKADMON CORP LLC·Filed 2015·Granted Sep 10, 2019·7 cites·7 claims
- 0258US2025195552A1Methods of using avermectin compositions for the treatment of inflammatory disorders and dosing regimensL4 BIO LLC·Filed 2023·Application pending·0 cites
- 0357US2025222017A1Methods of using avermectin compositions for the treatment of neurological disorders and dosing regimensL4 BIO LLC·Filed 2023·Application pending·0 cites
- 0457US2025205264A1Methods of using avermectin compositions for the treatment of spasticity and dosing regimensL4 BIO LLC·Filed 2023·Application pending·0 cites
- 0557US2025222018A1Methods of using avermectin compositions for the treatment of pain and dosing regimensL4 BIO LLC·Filed 2023·Application pending·0 cites
- 0653US2025195551A1Liquid formulations of ivermectin compositions and use in gelatin dosage formsL4 BIO LLC·Filed 2023·Application pending·0 cites
- 0753US2024366604A1Selective inhibitors of rock2 for the treatment of muscular dystrophyGRAVITON BIOSCIENCE BV·Filed 2022·Application pending·0 cites
- 0853US2024059775A9Immunomodulatory agentsKADMON CORP LLC·Filed 2020·Application pending·0 cites
- 0953US2015010545A1Methods for treatment of breast cancer nonresponsive to trastuzumabKADMON CORP LLC·Filed 2012·Application pending·0 cites
- 1053US2009232805A1Methods of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonistWAKSAL SAMUEL·Filed 2009·Application pending·0 cites
- 1151US2024165116A1Rock2 inhibitor for the treatment of viral infectionGRAVITON BIOSCIENCE B V·Filed 2022·Application pending·0 cites
- 1247US2025289807A1Inhibitors of ROCK2GRAVITON BIOSCIENCE BV·Filed 2023·Application pending·0 cites
- 1345US2023021959A1Stabilization of Retromer for the Treatment of Alzheimer's Disease and Other Neurodegenerative DisordersUNIV COLUMBIA·Filed 2020·Application pending·0 cites
- 1445US2023028307A1Treatment of neurological disorders with avermectinsEQUILIBRE BIOPHARMACEUTICALS BV·Filed 2021·Application pending·0 cites
- 1545US2007036795A1Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonistWAKSAL SAMUEL·Filed 2004·Application pending·0 cites
- 1644US9586940B2Methods for treatment of breast cancer nonresponsive to trastuzumabKADMON CORP LLC·Filed 2015·Granted Mar 7, 2017·0 cites·10 claims
- 1743US2012201817A1Methods of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonistWAKSAL SAMUEL·Filed 2012·Application pending·0 cites
- 1841US10874624B2Stable trientine formulationsKADMON PHARMACEUTICALS LLC·Filed 2016·Granted Dec 29, 2020·0 cites·19 claims
- 1936US2014363396A1Once daily treatment of hepatitis c with ribavirin and taribavirinKADMON PHARMACEUTICALS LLC·Filed 2013·Application pending·0 cites
- 2029US10080752B2Treatment of brain and central nervous system tumorsKADMON CORP LLC·Filed 2015·Granted Sep 25, 2018·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Samuel D. Waksal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →